GCVI Summit 2018
Skip Content

20 April 2017

Illumina increases CVC fund to $189m

The genomics technology producer has boosted the size of the corporate venture capital unit it announced in April last year from $100m to $189m with a $250m ceiling.

Author: Robert Lavine, News Editor

US-based genomics technology provider Illumina has increased the size of its corporate venturing unit from $100m to approximately $189m and could close it at $250m, according to a securities filing on Tuesday.